Literature DB >> 10720953

Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.

S N Wang1, J LaPage, R Hirschberg.   

Abstract

BACKGROUND: The present in vivo and in vivo experiments were performed to test the hypothesis that in rats with glomerular proteinuria, the bioactive growth factors transforming growth factor-beta (TGF-beta) and hepatocyte growth factor (HGF) are ultrafiltered into tubular fluid, can interact with respective receptors in apical tubular cell membranes, increase the expression and basolateral secretion of C-C-chemokines, which interact with cells in the renal interstitium and indirectly cause myofibroblasts to increase the expression of extracellular matrix proteins.
METHODS: HGF and TGF-beta were measured by Western blot and bioassay in glomerular ultrafiltrate that was collected by nephron micropuncture from rats with diabetic nephropathy and control rats. Proximal tubular and collecting duct cells were incubated with diluted proximal tubular fluid or recombinant human HGF (rhHGF) or rhTGF-beta and expression of C-C-chemokines was measured by RT-PCR and ELISA. Interactions of tubular cell chemokines with macrophages and indirectly with myofibroblasts were also examined using cell culture models.
RESULTS: In rats with glomerular proteinuria due to diabetic nephropathy mature, bioactive HGF as well as active and latent TGF-beta were detected in early proximal tubular fluid. Specific HGF- and TGF-beta type II receptors were expressed in apical tubular membranes more in diabetic compared to control rats. Incubation of cultured mouse proximal tubular cells (mPTC) or medullary collecting duct cells (mIMCD-3) with diabetic rat proximal tubular fluid increased MCP-1 and RANTES mRNA levels as well as secreted peptide up to threefold. In contrast, high glucose (450 mg/dL), bovine serum albumin (BSA) or rat albumin (each at 100 micrograms/mL) or 10 nmol/L insulin-like growth factor-I (IGF-I; which was also present in glomerular ultrafiltrate in rats with diabetic nephropathy) did not affect expression of these chemokines. Recombinant human TGF-beta as well as rhHGF each increased MCP-1 and RANTES mRNA as well as peptide levels several-fold. In cultured macrophages MCP-1 raised the secretion of TGF-beta, which in turn increased the expression of collagen type I and III as well as fibronectin in renal interstitial myofibroblasts about 2.5 to 4-fold.
CONCLUSIONS: Proteinuria-induced progressive renal interstitial fibrosis may be caused by glomerular ultrafiltration of high molecular weight bioactive growth factors, HGF and TGF-beta, which "activate" tubular cells through apical membranes. These apical signals are translated into basolateral events that are recognized by cells in the interstitium, such as the basolateral secretion of the C-C-chemokines MCP-1 and RANTES, which may (via macrophages) stimulate interstitial myofibroblasts, and thus lead to accumulation of extracellular matrix proteins and progressive interstitial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720953     DOI: 10.1046/j.1523-1755.2000.00928.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  32 in total

1.  Transforming growth factor-beta1 reduces megalin- and cubilin-mediated endocytosis of albumin in proximal-tubule-derived opossum kidney cells.

Authors:  Michael Gekle; Petra Knaus; Rikke Nielsen; Sigrid Mildenberger; Ruth Freudinger; Verena Wohlfarth; Christoph Sauvant; Erik I Christensen
Journal:  J Physiol       Date:  2003-10-15       Impact factor: 5.182

2.  Association between urinary IgG and relative risk for factors affecting proteinuria in type 2 diabetic patients.

Authors:  Sandesh Mohan; Kiran Kalia; Jyoti Mannari
Journal:  Indian J Clin Biochem       Date:  2012-06-24

3.  Temporal characterization of the development of renal injury in FHH rats and FHH.1BN congenic strains.

Authors:  Jan Michael Williams; Marilyn Burke; Jozef Lazar; Howard J Jacob; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

4.  Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.

Authors:  Jan M Williams; Jin Zhang; Paula North; Steven Lacy; Michael Yakes; Annette Dahly-Vernon; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2011-01-12

5.  Localisation and phenotypical characterisation of collagen-producing cells in TGF-beta 1-induced renal interstitial fibrosis.

Authors:  Qing Chai; Søren Krag; Song Chai; Thomas Ledet; Lise Wogensen
Journal:  Histochem Cell Biol       Date:  2003-04-02       Impact factor: 4.304

6.  Resveratrol inhibits renal interstitial fibrosis in diabetic nephropathy by regulating AMPK/NOX4/ROS pathway.

Authors:  Ting He; Jiachuan Xiong; Ling Nie; Yanlin Yu; Xu Guan; Xinli Xu; Tangli Xiao; Ke Yang; Liang Liu; Daohai Zhang; Yunjian Huang; Jingbo Zhang; Junping Wang; Kumar Sharma; Jinghong Zhao
Journal:  J Mol Med (Berl)       Date:  2016-08-04       Impact factor: 4.599

7.  A molecular signature of proteinuria in glomerulonephritis.

Authors:  Heather N Reich; David Tritchler; Daniel C Cattran; Andrew M Herzenberg; Felix Eichinger; Anissa Boucherot; Anna Henger; Celine C Berthier; Viji Nair; Clemens D Cohen; James W Scholey; Matthias Kretzler
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

8.  Selective CCR2-targeted macrophage depletion ameliorates experimental mesangioproliferative glomerulonephritis.

Authors:  L M McIntosh; J L Barnes; V L Barnes; J R McDonald
Journal:  Clin Exp Immunol       Date:  2008-11-25       Impact factor: 4.330

9.  Expression of c-met stimulated by high glucose in human renal tubular epithelial cells and its implication.

Authors:  Li Xing; Zhang Muxun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-04

10.  Association of macroalbuminuria with oxidized LDL and TGF-beta in type 2 diabetic patients: a case-control study.

Authors:  Manouchehr Nakhjavani; Alireza Esteghamati; Omid Khalilzadeh; Firouzeh Asgarani; Nasrin Mansournia; Mehrshad Abbasi
Journal:  Int Urol Nephrol       Date:  2009-09-19       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.